| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks.
|
Nat Med
|
2001
|
16.65
|
|
2
|
Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.
|
N Engl J Med
|
1994
|
5.28
|
|
3
|
SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
|
N Engl J Med
|
1998
|
4.18
|
|
4
|
An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.
|
Oncogene
|
2009
|
4.10
|
|
5
|
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.
|
J Clin Oncol
|
1998
|
3.10
|
|
6
|
Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.
|
Clin Cancer Res
|
2001
|
2.80
|
|
7
|
Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
|
Am J Pathol
|
2001
|
2.68
|
|
8
|
Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell.
|
Cancer Res
|
2001
|
2.48
|
|
9
|
Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants.
|
J Clin Oncol
|
1998
|
2.34
|
|
10
|
Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney.
|
Am J Surg Pathol
|
2000
|
2.05
|
|
11
|
Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.
|
Diagn Mol Pathol
|
2000
|
1.91
|
|
12
|
Gene amplification in gastric and esophageal adenocarcinomas.
|
Cancer Res
|
1990
|
1.90
|
|
13
|
Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma.
|
Eur Respir J
|
2011
|
1.74
|
|
14
|
Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor.
|
Am J Pathol
|
2001
|
1.72
|
|
15
|
Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7.
|
Int J Cancer
|
2001
|
1.71
|
|
16
|
Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor.
|
Proc Natl Acad Sci U S A
|
1995
|
1.66
|
|
17
|
Cytokeratin immunoreactivity in Ewing's sarcoma: prevalence in 50 cases confirmed by molecular diagnostic studies.
|
Am J Surg Pathol
|
2000
|
1.64
|
|
18
|
Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms.
|
Am J Pathol
|
1994
|
1.60
|
|
19
|
EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.
|
J Clin Oncol
|
1999
|
1.58
|
|
20
|
Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study.
|
Cancer
|
1998
|
1.56
|
|
21
|
Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.
|
Clin Cancer Res
|
2000
|
1.46
|
|
22
|
Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.
|
J Pathol
|
2007
|
1.43
|
|
23
|
Administration of rabbit anti-asialo GM1 antiserum facilitates the development of human Epstein-Barr virus-induced lymphoproliferations in xenografted C.B-17 scid/scid mice.
|
Transplantation
|
1996
|
1.40
|
|
24
|
Olfactory neuroblastoma is not related to the Ewing family of tumors: absence of EWS/FLI1 gene fusion and MIC2 expression.
|
Am J Surg Pathol
|
1998
|
1.34
|
|
25
|
ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).
|
Am J Pathol
|
2000
|
1.31
|
|
26
|
Prognostic impact of P53 status in Ewing sarcoma.
|
Cancer
|
2000
|
1.27
|
|
27
|
Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
|
J Exp Med
|
1996
|
1.27
|
|
28
|
High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.
|
J Clin Oncol
|
2001
|
1.23
|
|
29
|
Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma.
|
Am J Pathol
|
2000
|
1.22
|
|
30
|
Mechanisms of methotrexate resistance in osteosarcoma.
|
Clin Cancer Res
|
1999
|
1.22
|
|
31
|
Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas.
|
J Mol Diagn
|
2000
|
1.21
|
|
32
|
Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy.
|
J Clin Oncol
|
1996
|
1.18
|
|
33
|
The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour.
|
Nat Genet
|
1997
|
1.17
|
|
34
|
Estrogen and progesterone receptor determination in the papillary cystic neoplasm of the pancreas. With immunohistochemical and ultrastructural observations.
|
Cancer
|
1987
|
1.17
|
|
35
|
Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases.
|
Mod Pathol
|
1998
|
1.16
|
|
36
|
Synovial sarcoma mimicking desmoplastic small round-cell tumor: critical role for molecular diagnosis.
|
Med Pediatr Oncol
|
1999
|
1.14
|
|
37
|
Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.
|
Cancer Res
|
1999
|
1.13
|
|
38
|
Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript.
|
Am J Pathol
|
1995
|
1.13
|
|
39
|
Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.
|
Oncogene
|
2003
|
1.11
|
|
40
|
Primary lymphomatous effusions in AIDS: a morphological, immunophenotypic, and molecular study.
|
Mod Pathol
|
1995
|
1.10
|
|
41
|
p53 and MDM2 alterations in osteosarcomas: correlation with clinicopathologic features and proliferative rate.
|
Cancer
|
1997
|
1.09
|
|
42
|
Prognostic impact of INK4A deletion in Ewing sarcoma.
|
Cancer
|
2000
|
1.08
|
|
43
|
Intracranial desmoplastic small-cell tumor. Report of a case.
|
Am J Surg Pathol
|
1996
|
1.06
|
|
44
|
Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing.
|
Ann Oncol
|
2014
|
1.05
|
|
45
|
Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment.
|
Genes Chromosomes Cancer
|
1991
|
1.05
|
|
46
|
CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons.
|
Int J Cancer
|
1999
|
1.04
|
|
47
|
Detection of chimeric transcripts in desmoplastic small round cell tumor and related developmental tumors by reverse transcriptase polymerase chain reaction. A specific diagnostic assay.
|
Am J Pathol
|
1995
|
1.01
|
|
48
|
The expanding clinical spectrum of desmoplastic small round-cell tumor: a report of two cases with molecular confirmation.
|
Hum Pathol
|
1999
|
0.98
|
|
49
|
Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma.
|
Am J Pathol
|
1997
|
0.98
|
|
50
|
The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene.
|
J Pathol
|
2009
|
0.97
|
|
51
|
Leukemic differentiation of a mediastinal germ cell tumor.
|
Genes Chromosomes Cancer
|
1989
|
0.96
|
|
52
|
Expression of bone morphogenetic proteins and receptors in sarcomas.
|
Clin Orthop Relat Res
|
1999
|
0.95
|
|
53
|
Molecular variants of the EWS-WT1 gene fusion in desmoplastic small round cell tumor.
|
Diagn Mol Pathol
|
1998
|
0.94
|
|
54
|
CD30 (Ki-1)-positive malignant lymphomas: clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's disease.
|
Blood
|
1996
|
0.92
|
|
55
|
Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib.
|
Cancer
|
2015
|
0.91
|
|
56
|
Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications.
|
Am J Pathol
|
2000
|
0.90
|
|
57
|
Analysis of nuclear and mitochondrial DNA alterations in thyroid and renal oncocytic tumors.
|
Cytogenet Cell Genet
|
1994
|
0.90
|
|
58
|
Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplification.
|
Genes Chromosomes Cancer
|
1990
|
0.89
|
|
59
|
Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma.
|
Leukemia
|
1990
|
0.88
|
|
60
|
Comparison of a multiplex reverse transcriptase-polymerase chain reaction for BCR-ABL to fluorescence in situ hybridization, Southern blotting, and conventional cytogenetics in the monitoring of patients with Ph1-positive leukemias.
|
Diagn Mol Pathol
|
2000
|
0.86
|
|
61
|
Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral T-cell lymphomas and lymphomas of uncertain lineage, including 12 Ki-1 positive lymphomas.
|
Genes Chromosomes Cancer
|
1990
|
0.86
|
|
62
|
11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas.
|
Cancer Res
|
1990
|
0.84
|
|
63
|
International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review.
|
J Clin Oncol
|
1996
|
0.84
|
|
64
|
Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone.
|
Sarcoma
|
1997
|
0.84
|
|
65
|
Peripheral T cell lymphoma in a patient with common variable immunodeficiency disease: case report and literature review.
|
Leuk Lymphoma
|
1999
|
0.84
|
|
66
|
CNV and time estimation.
|
Int J Neurosci
|
1985
|
0.81
|
|
67
|
Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers.
|
Eur J Cancer
|
1997
|
0.79
|
|
68
|
Peripheral primitive neuroectodermal tumors in adults: documentation by molecular analysis.
|
J Clin Oncol
|
1998
|
0.79
|
|
69
|
Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics?
|
Histopathology
|
2001
|
0.78
|
|
70
|
Re: O'Sullivan MJ, Kyriakos M, Zhu X, Wick MR, Swanson PE, Dehner LP, Humphrey PA, Pfeifer JD: malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study. Mod pathol 2000;13:1336-46.
|
Mod Pathol
|
2001
|
0.78
|
|
71
|
Association of clonal T-cell large granular lymphocyte disease and paroxysmal nocturnal haemoglobinuria (PNH): further evidence for a pathogenetic link between T cells, aplastic anaemia and PNH.
|
Br J Haematol
|
2001
|
0.77
|
|
72
|
Specificity of the EWS/WT1 gene fusion for desmoplastic small round cell tumour.
|
J Pathol
|
1996
|
0.77
|
|
73
|
Clinically critical impact of molecular genetic studies in pediatric solid tumors.
|
Med Pediatr Oncol
|
1999
|
0.77
|
|
74
|
Diagnosis and classification of small round-cell tumors of childhood.
|
Am J Pathol
|
1999
|
0.75
|
|
75
|
Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease.
|
Lancet
|
1995
|
0.75
|
|
76
|
Translating research into cancer molecular diagnostics and patents.
|
J Clin Pathol
|
2005
|
0.75
|
|
77
|
Residual sentience and cognitive death: ethical issues in brain death and the persistent vegetative state.
|
Can Med Assoc J
|
1984
|
0.75
|
|
78
|
Bcl-2 gene rearrangement in salivary gland lymphoma.
|
Am J Surg Pathol
|
1991
|
0.75
|
|
79
|
Variant t(8;14) translocations in non-Burkitt's non-Hodgkin's lymphomas.
|
Blood
|
1992
|
0.75
|
|
80
|
In-vivo labeling of (3H)D-aspartate uptake sites in monkey retina.
|
Cell Tissue Res
|
1986
|
0.75
|
|
81
|
Incidence of 5' bcl-2 rearrangement in patients with B cell chronic lymphocytic leukemia from India.
|
Leuk Res
|
1996
|
0.75
|
|
82
|
Proteinaceous (angiocentric sclerosing) lymphadenopathy: a polyclonal systemic, nonamyloid deposition disorder.
|
Blood
|
1995
|
0.75
|
|
83
|
Analysis of BCL2 and MYC expression in non-Hodgkin's lymphomas by in situ hybridization: correlation with chromosome translocations.
|
Diagn Mol Pathol
|
1992
|
0.75
|
|
84
|
Detection of BCL2 rearrangement in archival cytological smears of B-cell lymphomas.
|
Mod Pathol
|
1994
|
0.75
|
|
85
|
1999 Association for Molecular Pathology annual meeting.
|
J Mol Diagn
|
2000
|
0.75
|
|
86
|
Hypermutation of the MYC gene in diffuse large cell lymphomas with translocations involving band 8q24.
|
Genes Chromosomes Cancer
|
1993
|
0.75
|
|
87
|
Cytogenetic and molecular characterization of a malignant mixed müllerian tumor of the uterus with a t(8;22)(q24.1;q12).
|
Cancer Genet Cytogenet
|
1999
|
0.75
|
|
88
|
Rearrangement in the coding region of the MYCN gene in a subset of amplicons in a case of neuroblastoma with MYCN amplification.
|
Diagn Mol Pathol
|
2001
|
0.75
|
|
89
|
Structural alterations in the 5' region of the BCL2 gene in follicular lymphomas with BCL2-MBR or BCL2-MCR rearrangements.
|
Genes Chromosomes Cancer
|
1991
|
0.75
|